Manager, US Federal and State Tax Reporting (East Hanover, NJ) |
East Hanover |
USA |
Finance |
Corporate |
Audit & Finance |
Jun 04, 2024 |
Senior Medical Information Manager II |
INSURGENTES |
Mexico |
Operations |
CTS |
Research & Development |
Jun 04, 2024 |
Medical Director Hematology Franchise |
Remote Position (USA) |
USA |
US |
Innovative Medicines |
Research & Development |
Jun 04, 2024 |
Enterprise Architecture and Integration Director for Commercial Areas |
INSURGENTES |
Mexico |
Operations |
CTS |
|
Jun 04, 2024 |
AD, Operational Reporting, Analytics & Insights |
East Hanover |
USA |
US |
Innovative Medicines |
Marketing |
Jun 04, 2024 |
Senior/Advanced Medical/Sales Representative |
Zhangzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Jun 04, 2024 |
(高级)医药代表 /(资深)产品专员 |
Kelamayi (Xinjiang Province) |
China |
International |
Innovative Medicines |
Sales |
Jun 04, 2024 |
Senior/Advanced Medical/Sales Representative |
Zhangzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Jun 04, 2024 |
县域主任/县域主管 |
Luoyang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
Jun 04, 2024 |
Lead or Senior Lead, Medical (Solid) |
Tokyo |
Japan |
International |
Japan IMI |
Research & Development |
Jun 03, 2024 |
KAM Strategic Lead |
Kao Hsiung |
Taiwan |
International |
Innovative Medicines |
Sales |
Jun 03, 2024 |
KAM Strategic Lead |
Kao Hsiung |
Taiwan |
International |
Innovative Medicines |
Sales |
Jun 03, 2024 |
Lead/Associate, Medical Science-1 |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
Jun 03, 2024 |
KAM Strategic Lead |
Kao Hsiung |
Taiwan |
International |
Innovative Medicines |
Sales |
Jun 03, 2024 |
KAM Strategic Lead |
Kao Hsiung |
Taiwan |
International |
Innovative Medicines |
Sales |
Jun 03, 2024 |
Head, Payeurs du secteur privé |
Field Non-Sales (Canada) |
Canada |
International |
Innovative Medicines |
Market Access |
Jun 03, 2024 |
KAM Strategic Lead |
Kao Hsiung |
Taiwan |
International |
Innovative Medicines |
Sales |
Jun 03, 2024 |
KAM Strategic Lead |
Kao Hsiung |
Taiwan |
International |
Innovative Medicines |
Sales |
Jun 03, 2024 |
Order to Cash and Treasury Cash Management Manager ACC |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
Jun 03, 2024 |
Alternant CHEF DE PROJET RSE |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
International |
Innovative Medicines |
|
Jun 03, 2024 |
KAM Strategic Lead |
Kao Hsiung |
Taiwan |
International |
Innovative Medicines |
Sales |
Jun 03, 2024 |
KAM Strategic Lead |
Kao Hsiung |
Taiwan |
International |
Innovative Medicines |
Sales |
Jun 03, 2024 |
Sr. Specialist - Process Mining |
Hyderabad (Office) |
India |
Operations |
CTS |
|
Jun 03, 2024 |
LDC Security Manager-1 |
Prague |
Czech Republic |
Operations |
CTS |
Audit & Finance |
Jun 03, 2024 |
Director, Innovation Lab MAVA Lead |
Remote Position (USA) |
USA |
US |
Innovative Medicines |
Marketing |
Jun 03, 2024 |
Manager - FFO Analytics |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Jun 03, 2024 |
Cash Management Bank Reconciliation M&A |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
Jun 03, 2024 |
Technicien laboratoire - Prélèvement & Microbiologie (h/f) |
Huningue |
France |
Operations |
Innovative Medicines |
Technical Operations |
Jun 03, 2024 |
Maintenance Technician (Mechatronics) |
Schaftenau |
Austria |
Operations |
Innovative Medicines |
Technical Operations |
Jun 03, 2024 |
Maintenance Planner |
Durham |
USA |
Operations |
Innovative Medicines |
Facilities & Administration |
Jun 03, 2024 |
KAM Strategic Lead |
Kao Hsiung |
Taiwan |
International |
Innovative Medicines |
Sales |
Jun 03, 2024 |
Lead, Capability Learning Solutions |
Remote |
India |
Development |
Innovative Medicines |
Human Resources |
Jun 03, 2024 |
Supply Chain Project Lead |
Durham |
USA |
Operations |
Innovative Medicines |
Technical Operations |
Jun 03, 2024 |
Head, Private Payers |
Field Non-Sales (Canada) |
Canada |
International |
Innovative Medicines |
Market Access |
Jun 03, 2024 |
Senior Process Engineer, Multidiscipline |
Remote Position (USA) |
USA |
Operations |
Innovative Medicines |
Technical Operations |
Jun 03, 2024 |
Change Control Coordinator |
Hyderabad (Office) |
India |
Operations |
Innovative Medicines |
Technical Operations |
Jun 03, 2024 |
Talent Acquisition Business Partner |
Hyderabad (Office) |
India |
People & Organization |
CTS |
Human Resources |
Jun 03, 2024 |
Associate Director, Global Security Investigator |
Mapletree Business City (MBC) |
Singapore |
Corporate |
Corporate |
Legal & Intellectual Property & Compl. |
Jun 03, 2024 |
Talent Acquisition Business Partner |
Hyderabad (Office) |
India |
People & Organization |
CTS |
Human Resources |
Jun 03, 2024 |
KAM Strategic Lead |
Kao Hsiung |
Taiwan |
International |
Innovative Medicines |
Sales |
Jun 03, 2024 |
P&O Manager,People Partner |
Shanghai (Shanghai) |
China |
People & Organization |
Innovative Medicines |
Human Resources |
Jun 03, 2024 |
KAM Strategic Lead |
Kao Hsiung |
Taiwan |
International |
Innovative Medicines |
Sales |
Jun 03, 2024 |
Medical Head Radioligand Therapy |
Rueil-Malmaison |
France |
International |
Innovative Medicines |
Research & Development |
Jun 02, 2024 |
Sales Representative Brustkrebs (d/w/m) Hessen |
Hessen (Novartis Pharma GmbH) |
Germany |
International |
Innovative Medicines |
Sales |
Jun 02, 2024 |
Analyst |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Jun 02, 2024 |
Analyst |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Jun 02, 2024 |
Senior Analyst |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Jun 02, 2024 |
Specialist Representative |
Makati City |
Philippines |
International |
Innovative Medicines |
Sales |
Jun 02, 2024 |
Dir, Integrated Insights - GEP-NET |
East Hanover |
USA |
US |
Innovative Medicines |
Marketing |
Jun 01, 2024 |
Time Service Delivery Expert - German Speaking. |
Cairo |
Egypt |
People & Organization |
P&O People Services and Technology |
Human Resources |
May 31, 2024 |